Pfizer Study: A Longitudinal Study to Evaluate the Efficacy of Bapineuzumab in Apolipoprotein E ε4 Carriers for the Treatment of Alzheimer’s Disease

The PI of this project was: Sanjay Asthana, MD

This project was funded by: Wyeth Pharmaceuticals, Inc.

The term of this project was: June 2010 to December 2014

The number of subjects scanned during this project was: 5